Cargando…
Methylene blue inhibits replication of SARS-CoV-2 in vitro
In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus diseases 2019 (COVID-19) emerged in Wuhan, China. Currently there is no antiviral treatment recommended against SARS-CoV-2. Identifying effective antiviral drugs is urgently requi...
Autores principales: | Gendrot, Mathieu, Andreani, Julien, Duflot, Isabelle, Boxberger, Manon, Le Bideau, Marion, Mosnier, Joel, Jardot, Priscilla, Fonta, Isabelle, Rolland, Clara, Bogreau, Hervé, Hutter, Sébastien, La Scola, Bernard, Pradines, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566888/ https://www.ncbi.nlm.nih.gov/pubmed/33075512 http://dx.doi.org/10.1016/j.ijantimicag.2020.106202 |
Ejemplares similares
-
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2021) -
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
por: Delandre, Océane, et al.
Publicado: (2022)